Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    11283304 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity
Condition: Apnea of Prematurity
Interventions: Other: CO2 inhalation;   Drug: Theophylline

Study has passed its completion date and status has not been verified in more than two years.